Prevalence and risk factors for Hepatitis C viral infection amongst a cohort of Irish drug users attending a drug treatment centre for Agonist Opioid Treatment (AOT)
Saved in:
Keegan, D., et al., Prevalence and risk factors for Hepatitis C viral infection amongst a cohort of Irish drug users attending a drug treatment centre for Agonist Opioid Treatment (AOT). Heroin Addiction & Related Clinical Problems, vol. 19, n. 1, 2017, p. 47-56.
Ref.
521959
Location:
SIIS Archivo (R.1828)
Palabras clave:
Drogodependencias, Opiáceos, Programas de mantenimiento, Hepatitis, Factor de riesgo, Mujer, Hombre, Datos epidemiológicos, Irlanda
Drogodependencias, Opiáceos, Programas de mantenimiento, Hepatitis, Factor de riesgo, Mujer, Hombre, Datos epidemiológicos, Irlanda
Similar Items: Prevalence and risk factors for Hepatitis C viral infection amongst a cohort of Irish drug users attending a drug treatment centre for Agonist Opioid Treatment (AOT)
- Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users
- THE NATURAL HISTORY OF HEPATITIS C VIRUS INFECTION: HOST, VIRAL AND ENVIRONMENTAL FACTORS
- PREDICTORS OF HEPATITIS B AND C INFECTION IN INJECTING DRUG USERS BOTH IN AND OUT OF DRUG TREATMENT
- Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review
- FACTORS ASSOCIATED WITH UPTAKE OF TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTING DRUG USER COHORT: THE ATAHC STUDY
- Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study